Amylyx Pharmaceuticals, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
AMLX Nasdaq 2830 amylyx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Amylyx Pharmaceuticals, Inc.

Amylyx Pharmaceuticals Gains FDA Fast Track for ALS Drug AMX0114 - Jun 24th, 2025 10:46 am
Amylyx Pharmaceuticals Receives U.S. FDA Fast Track Designation for AMX0114 for the Treatment of Amyotrophic Lateral Sclerosis - Jun 3rd, 2025 5:00 am
Amylyx Pharmaceuticals to Participate in Upcoming June Investor Conferences - May 21st, 2025 5:00 am
Wall Street Analysts See a 105.22% Upside in Amylyx Pharmaceuticals (AMLX): Can the Stock Really Move This High? - May 20th, 2025 7:55 am
Amylyx Pharmaceuticals Announces Positive Long-Term Results from Phase 2 HELIOS Clinical Trial of AMX0035 in People with Wolfram Syndrome - May 12th, 2025 5:00 am
Here's Why We're A Bit Worried About Amylyx Pharmaceuticals' (NASDAQ:AMLX) Cash Burn Situation - May 10th, 2025 6:51 am
Amylyx Pharmaceuticals Inc (AMLX) Q1 2025 Earnings Call Highlights: Strategic Advances and ... - May 9th, 2025 1:12 am
Amylyx Pharmaceuticals Reports First Quarter 2025 Financial Results - May 8th, 2025 5:00 am
Amylyx Pharmaceuticals to Participate in Upcoming May Investor Conferences - May 7th, 2025 6:00 am
Amylyx Pharmaceuticals to Report First Quarter 2025 Financial Results on May 8, 2025 - May 1st, 2025 7:00 am
Amylyx doses first subject in trial of post-bariatric hypoglycaemia treatment - May 1st, 2025 4:06 am
Amylyx Pharmaceuticals Announces First Participant Dosed in Pivotal Phase 3 LUCIDITY Trial of Avexitide in Post-Bariatric Hypoglycemia - Apr 30th, 2025 5:00 am
Is Amylyx Pharmaceuticals Inc. (NASDAQ:AMLX) the Best Biotech Penny Stock to Buy According to Hedge Funds? - Apr 16th, 2025 9:22 am
First subject dosed in Amylyx’s Phase I trial of ALS therapy - Apr 10th, 2025 5:03 am
Amylyx Pharmaceuticals Announces First Participant Dosed in Phase 1, Multiple Ascending Dose LUMINA Trial of AMX0114 in People Living with Amyotrophic Lateral Sclerosis - Apr 9th, 2025 5:00 am
Amylyx Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference - Apr 2nd, 2025 7:00 am
Is Amylyx Pharmaceuticals (AMLX) The Hot Biotech Stock Under $5? - Mar 27th, 2025 8:17 am
March 2025's Top Penny Stocks To Watch - Mar 6th, 2025 4:05 am
Amylyx Pharmaceuticals Inc (AMLX) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ... - Mar 5th, 2025 8:01 am
Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results - Mar 4th, 2025 4:00 am